期刊文献+

老年死亡病例医院感染分析 被引量:3

Analysis of nosocomial infections in elder death cases
原文传递
导出
摘要 目的分析老年死亡病例医院感染分布特点、病原菌类型及其耐药特征。方法回顾性调查分析医院2009年1月-2012年4月237份老年死亡病历资料。结果 237例死亡患者中发生医院感染109例、113例次,医院感染率为46.0%、例次感染率为47.68%;恶性肿瘤和呼吸系统疾病患者医院感染率最高,分别为54.29%和50.00%;感染部位以呼吸道为主,占73.45%;病原菌以革兰阴性杆菌为主占69.14%,革兰阳性球菌占20.22%,真菌占10.64%;铜绿假单胞菌、大肠埃希菌、金黄色葡萄球菌对多数抗菌药物的耐药率>50.00%。结论老年死亡病例中医院感染率高,病原菌对常用抗菌药物的耐药率高、耐药谱广,高度重视感染患者的病原菌鉴定及药敏试验,定期监测细菌耐药性,为临床合理使用抗菌药物,控制医院感染具有重要意义。 OBJECTIVE To analyze the distribution and drug resistance characteristic of the pathogenic bacteria causing nosoeomial infections in elder death cases. METHODS The clinical data of eider inpatients who died in hospital from Jan. 2009 to Apr. 2012 were investigated and analyzed retrospectively. RESULTS Of the 237 elder death cases, nosocomial infections occurred in 109 cases with 113 case-times, with the infection rate of 46.0% and case-time infection rate of 47.68%. The malignant tumor and respiratory system diseases were with the highest infection rate (54. 29% and 50. 0%, respectively). The respiratory tract was the main infected location, accounting for 73. 45%. Gram-negative bacilli were the predominant pathogens (69.14%), followed by gram- positive cocci and fungi (20.22% and 10.64%, respectively). The resistant rates of Pseudomonas aeruginosa, Escherichia coli and Staphylococcus aureus to most antibiotics were higher than 50.0%. CONCLUSIONS The rate of nosocomial infection in eider death cases is high, and the pathogens possess broad antibiotic resistance spectrum and higher antibiotic resistance rate. Great emphasis on the identification and drug sensitive test of bacteria and regular surveillance for bacterial resistance have great significance in clinical reasonable use of antibiotics and the control of nosocomial infections.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2014年第11期2722-2724,共3页 Chinese Journal of Nosocomiology
基金 湖北省卫生厅科研基金资助项目(JX6B11)
关键词 老年患者 死亡 医院感染 耐药性 Elder inpatient Deathl Nosocomial infection Drug resistance
  • 相关文献

参考文献9

二级参考文献44

共引文献157

同被引文献34

  • 1Chen SL,Jiang B, Qiu LG, et al. Bortezomib plus thalidomide {ornewly diagnosed multiple myeloma in China[J]. Anat Rec (Hoboken) ,2010,293(10) :1679-1684.
  • 2Chanan-Khan A, Sonneveld P, Schuster MW, et al. Analysis of herpes zoster events among bortezomib-treated patients in the phase Ⅲ APEX study[J]. J Clin Oncol, 2008,26 (29) : 4784-4790.
  • 3Blanco B, P6rez-Sim6n JA, Sdnchez-Abarca LI, et al. Borte- zomib induees selective depletion of alloreaetive T lympho- cytes and decreases the production of Thl cytokines [J]. Blood, 2006,107(9) : 3575-3583.
  • 4Fukushima T, Sato T, Nakamura T, et al. Daily 500mg vala- eyelovir is effective for prevention of Varieella zoster virus re- activation in patients with multiple myeloma treated with bortezomib[J]. Antieancer Res, 2012,32(12) : 5437-5440.
  • 5Moreau P,Karamanesht II,Domnikova N,et al.Pharmacokinetic,pharmacodynamic and covariate analysis of subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma[J].Clin Pharmacokinet,2012,51(12):823-829.
  • 6Petrucci MT,Giraldo P,Corradini P,et al.A prospective,international phase 2.study of bortezomib retreatment in patients with relapsed multiple myeloma[J].Br J Haematol,2013,160(5):649-659.
  • 7Bringhen S,Mateos MV,Zweegman S,et al.Age and organ damage correlate with poor survival in myeloma patients:meta-analysis of 1435individual patient data from 4randomized trials.[J].Haenzatologica,2013,98(6):980-987.
  • 8Jakubowiak AJ,Dytfeld D,Griffith KA,et al.A phase 1/2study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma[J].Blood,2012,120(9):1801-1809.
  • 9隋冰冰.强化口腔护理在预防ICU昏迷病人并发坠积性肺炎中的应用[J].护士进修杂志,2012,27(15):1414-1415. 被引量:24
  • 10张桂兰,沈云霞,张晓琳,范煜,万青.冰茶灵洗剂口腔护理预防危重症患者内源性感染的发生[J].中国中医急症,2012,21(10):1716-1717. 被引量:13

引证文献3

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部